Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial
Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva, Thiago Ceccatto de Paula, Renata Moll‐Bernardes, Tiago Mendonça dos Santos, Lilian Mazza, André Feldman, Guilherme Arruda, Denílson Campos de Albuquerque, Andréa Silvestre de Sousa, Olga Ferreira de Souza, C. Michael Gibson, Christopher B. Granger, John H. Alexander, Renato D. Lópes
Topics & Concepts
MedicineDiscontinuationCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseSeverity of illnessInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Pharmacological Receptor Mechanisms and Effects